The largest database of trusted experimental protocols

Apc conjugated anti cd3

Manufactured by Thermo Fisher Scientific
Sourced in United States

APC-conjugated anti-CD3 is a monoclonal antibody that binds to the CD3 complex, a component of the T-cell receptor. The antibody is conjugated with allophycocyanin (APC), a fluorescent dye, for detection and analysis purposes.

Automatically generated - may contain errors

7 protocols using apc conjugated anti cd3

1

Generating MART-1-specific CD8+ T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs from HLA-A*02:01 patients were used to generate DCs, which were subsequently pulsed with 20 μg/ml of MART-1 26-35 A27L (ELAGIGILTV) peptide (MBL, Medical & Biological Laboratories Co., Ltd., Nagoya, Japan) at 37 °С for 1 h. After washing with AIM-V medium, DCs were treated with mitomycin C (25 μg/ml; Kyowa Hakko Kogyo Co, Ltd, Tokyo, Japan) at 37 °C for 1 h. After two washes, the prepared DCs were used as stimulator cells; non-adherent PBMCs collected after seeding into plastic tissue-culture plates were used as responder cells. Stimulator (1 × 106) and responder cells were co-cultured at a ratio of 1:10 in AIM-V medium supplemented with IL-2 (2.5 U/ml; Imunace, Shionogi, Pharmaceutical, Osaka, Japan), IL-7 (5 ng/ml; R&D Systems) and IL-15 (10 ng/ml; PeproTech, Rocky Hill, NJ, USA) for 3−5 days. AIM-V media supplemented with 10% foetal bovine serum (FBS; Thermo Fisher Scientific K.K., Yokohama, Japan) was added depending on cell expansion. After a 2–3-day incubation, cells were harvested and stained with FITC-conjugated anti-CD8 (Beckman Coulter, Inc., Brea, CA, USA) and APC-conjugated anti-CD3 (eBioscience) mAbs and T-select HLA-A*02:01 MART-1 tetramer-ELAGIGILTV-PE (MBL).
+ Open protocol
+ Expand
2

Flow Cytometry Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell suspensions were prepared from spleen, lymph nodes, VAT, or liver of ob/ob mice as previously described (Chang et al., 2015 (link); Xiang et al., 2016 (link)). DC single-cell suspensions were obtained from bone marrow following standard procedures. Cells were stained with antibodies against the following cell surface antigens: fluorescein isothiocyanate (FITC)-conjugated anti-CD86, allophycocyanin (APC)-conjugated anti-CD11c, phycoerythrin (PE)-conjugated anti-MHC-II and PE-conjugated anti-PD-L1 (eBioscience, USA); APC-conjugated anti-Foxp3, FITC-conjugated anti-CD4, PE-conjugated anti-CD25 (eBioscience, USA); APC-conjugated anti-CD3, PE-conjugated anti-PD-1, and PE-conjugated anti-TCRβ (eBioscience, USA). Samples were detected on a BD LSRII flow cytometer or BD C6 (BD Pharmingen), and data were analyzed with Flowjo software, version 10.1.
+ Open protocol
+ Expand
3

Multiparametric Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions were preincubated with FcγR-specific blocking mAb (2.4G2) and washed before staining. Cells were stained with the following antibodies Percp-cy5-conjugated anti-CD45 (eBioscience), APC-conjugated anti-F4/80 (eBioscience), PE-cy7-conjugated conjugated anti-CD11c (eBioscience), FITC–conjugated anti-CD206 (BioLegend), APC-conjugated anti-CD3 (eBioscience), FITC–conjugated anti-CD4 (eBioscience); For intracellular staining, cells were permeabilized (Cytofix/Cytoperm kit; BD Biosciences) and incubated with PE–conjugated anti-IL-4, PE–conjugated anti-IL-5, PE–conjugated anti-IFN-γ (eBioscience), rabbit anti-Ym-1 (Stem Cell Technologies) and PE–conjugated anti-rabbit IgG (eBioscience). Cells were analyzed on a LSRII (BD Biosciences) with FlowJo ver.10 software (TreeStar).
+ Open protocol
+ Expand
4

Flow Cytometry Analysis of Immune Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
LP cells from colon or splenic immune cells were sorted using a FACS flow cytometer (BD Biosciences, San Jose, CA) and analyzed using FlowJo_V10 (Treestar, Ashlan, OR). The gating strategy has been shown in supplementary Figure 8. For macrophage and neutrophil analyses, cells were incubated with the following antibodies: FITC-conjugated anti-CD11b (11-0112-82, eBioscience, San Diego, CA), APC-conjugated anti-CD11c (17-0114-81, eBioscience), PE-cyanine7-conjugated anti-F4/80 (25-4801-82, eBioscience), PE-conjugated anti-CD206 (12-2061-80, eBioscience), and PE-conjugated anti-Ly6G (12-5931-81, eBioscience); for T cell analyses, cells were incubated with the following antibodies: APC-conjugated anti-CD3 (17-0032-82, eBioscience), FITC-conjugated anti-CD4 (11-0042-81, eBioscience), and PE-conjugated anti-CD8 (12-0081-81, eBioscience); for B cell and NK cell analyses, cells were incubated with the following antibodies: FITC-conjugated anti-CD19 (11-0193-81, eBioscience), and PE-conjugated anti-NK1.1 (12-5941-81, eBioscience).
+ Open protocol
+ Expand
5

MDSC Suppression of T Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly isolated tumor cells from TC-1 tumors were stained with the following fluorophore-conjugated antibodies: PeCy7-conjugated anti-CD11b, FITC-conjugated anti-Gr1 and APC-conjugated anti-CD3 (eBioscience, catalog nr. 25-0112-82, 11-5931-82, 17-0031-82). Cells were washed and sorted on a FACS MoFloAstrios (Beckman Coulter) based on forward and sideward scatter. Cells were positively sorted into CD11b+Gr1+ MDSCs and negatively sorted into CD3+ T cells. As determined by flow cytometric re-analysis, the purity of the sorted MDSCs was >92%.
Spleens cells isolated from donor mice immunized twice with 5 × 106 SFVeE6,7 particles were cultured in 96-well round bottom plates for 7 d. On day 0 of culture, flow-sorted MDSCs, isolated from TC-1 tumors, were added at different ratios to these cultures. On day 4 of culture, cells were labeled with carboxyfluorescein succinimidyl ester (CFSE; Invitrogen, catalog nr. C34554) for 10 min at 37oC. On day 5 of co-culture, recombinant IL-2 was added to the co-culture at a concentration of 5U/mL. As negative controls, splenocytes were cultured without stimulant. As positive controls, splenocytes were stimulated and cultured in the absence of MDSCs. At the end of the co-culture period, cells were collected and used for analysis.
+ Open protocol
+ Expand
6

Quantification of Th1 and Th17 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ T cells were stimulated for 4 hours with PMA (100 ng/ml) and ionomycin (1 μg/ml) in the presence of GolgiStop™ (BD Biosciences, San Jose, CA). Cells were then washed and stained with APC-conjugated anti-CD3 (Clone 17A2, eBioscience, San Diego, CA). After fixing and permeabilizing the cells with BD Cytofix/Cytoperm™ (BD Biosciences, San Jose, CA), staining for intracellular PE-conjugated anti-IFN-γ (Clone XMG1.2, eBioscience, San Diego, CA) and FITC-conjugated anti-IL-17A (Clone eBio17B7, eBioscience, San Diego, CA) was performed. Flow cytometry samples were run on a CyAn™ ADP Analyzer (Beckman Coulter, Brea, CA) and analyzed using Summit v4.3 (Beckman Coulter, Brea, CA).
+ Open protocol
+ Expand
7

Immunophenotyping and Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fas ligand (FasL) antibodies (SC-33716, Santa Cruz Biotechnology, USA) and anti-β-actin antibody (A1978, Sigma-Aldrich, USA) were used. Allophycocyanin (APC)-conjugated anti-IFN-γ, phycoerythrin (PE)-conjugated anti-IL-17, APC-conjugated anti-CD3, APC-conjugated anti-CD25, and peridinin chlorophyll protein complex (Percp)-conjugated anti-CD4 antibodies were purchased from eBioscience. Anti-CD45, CD73, CD90, CD105, and CD146 conjugated with PE and anti-CD34 and STRO1 conjugated with FTIC were purchased from BD Biosciences (Franklin Lakes, USA). BrdU solution and BrdU imaging kit were purchased from Invitrogen (Carlsbad, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!